SCHEMBL22856471

SCHEMBL22856471

CCNC(=O)COCCOCCOCCOCCNC(=O)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
GLP1R P43220 8/20 0.42
CAPN1 P07384 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 2/20 0.32
USP2 O75604 1/20 0.32
RAB9A P51151 2/20 0.32
HPGD P15428 1/20 0.32
NPC1 O15118 1/20 0.32
RECQL P46063 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21105905 1.00 KMT2A (0.54) KMT2AMEN1GLP1RCAPN1CYP2D6
SCHEMBL22856474 0.89 KMT2A (0.53) KMT2AMEN1GLP1RCYP2D6CYP2C9
SCHEMBL25122775 0.89 KMT2A (0.53) KMT2AMEN1GLP1RCYP2D6CYP2C9
SCHEMBL24765414 0.88 MEN1 (0.51) KMT2AMEN1GLP1RCAPN1SMN1; SMN2
SCHEMBL21786694 0.87 KMT2A (0.54) KMT2AMEN1GLP1RCAPN1CYP2D6
SCHEMBL22790865 0.87 MEN1 (0.54) KMT2AMEN1GLP1RTSHRUSP2
SCHEMBL22861922 0.87 MEN1 (0.54) KMT2AMEN1GLP1RTSHRUSP2
SCHEMBL25123451 0.86 KMT2A (0.50) KMT2AMEN1GLP1RCYP2D6CYP2C9
SCHEMBL25028591 0.86 KMT2A (0.53) KMT2AMEN1GLP1RCYP2D6CYP2C9
SCHEMBL22837784 0.86 KMT2A (0.53) KMT2AMEN1GLP1RCYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148060-A1 MK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-07-11 WO disclosed
WO-2020264490-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed